Relationships Between Symptoms and Lung Function in Asthma and/or Chronic Obstructive Pulmonary Disease in the NOVELTY study
Papi, A., Hughes, R., Olmo, R. d., Agusti, A., Chipps, B. E., Make, B., Tomaszewski, E., Peres Da Costa, K., Srivastava, D., Vestbo, J., Janson, C., Burgel, P., Price, D.
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
Porsbjerg, C. M., Menzies-Gow, A., Tran, T. N., Murray, R. B., Unni, B., Ang, S. L. A., Alacqua, M., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Belevskiy, A. S., Björnsdóttir, U. S., Bourdin, A., Busby, J., Walter Canonica, G., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Iwanaga, T., Jackson, D. J., Kocks, J. W. H., Kallieri, M., Bruce Ko, H., Siyue, M. K., Larenas-Linnemann, D., Lehtimäki, L. A., Loukides, S., Lugogo, N., Maspero, J. F., Papaioannou, A. I., Perez de Llano, L., Márcio Pitrez, P., Popov, T. A., Rasmussen, L. M., Rhee, C. K., Sadatsafavi, M., Schmidt, J., Siddiqui, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Upham, J. W., Eileen, W., Wechsler, M. E., Bulathsinhala, L., Carter, V., Chaudhry, I., Eleangovan, N., Hosseini, N., Rowlands, M., Price, D., van Boven, J. F.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 5
Variation in demographic and clinical characteristics of Patients with COPD receiving care in U.S. primary care: data from the Advancing the Patient EXperience (APEX) in COPD registry
Fox, C., Pace, W. D., Brandt, E., Chang, K., Edwards, C. L., Evans, A., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W., Kruszyk BEng, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
Pragmatic and Observational Research, vol. 2022, no. 13, pp. 17-31
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)
Cotton, S., Devereux, G., Abbas, H., Briggs, A. H., Campbell, K., Chaudhuri, R., Choudhury, G., Dawson, D., De Soyza, A., Fielding, S., Gompertz, S., Haughney, J., Lang, C. C., Lee, A., MacLennan, G., MacNee, W., McCormack, K., McMeekin, N., Mills, N. L., Morice, A., Norrie, J., Petrie, L., Price, D., Short, P., Vestbo, J., Walker, P., Wedzicha, J. A., Wilson, A., Lipworth, B. J.
Asthma exacerbation and steroid burden in Australian primary care
Price, D., Hancock, K. L., Bosnic-Anticevich, S., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Feldman-Stewart, D., Thompson, P., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., OPCA Improving Asthma outcomes in Australia Research Group
The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 194
No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
Lower pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 81
CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients
Alves, L., Pullen, R., Hurst, J. R., Miravitlles, M., Carter, V., Chen, R., Couper, A., Dransfield, M., Evans, A., Hardjojo, A., Jones, D., Jones, R., Kerr, M., Kostikas, K., Marshall, J., Martinez, F. J., van Melle, M., van Melle, M., Murray, R. B., Muro, S., Nordon, C., Pollack, M., Price, C., Sharma, A., Singh, D., Winders, T. A., Price, D.
Patient Related Outcome Measures, vol. 2022, no. 13, pp. 53-68
Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone
Price, D., Henley, W., Delfini Cançado, J. E., Fabbri, L. M., Kerstjens, H. A., Papi, A., Roche, N., Şen, E., Singh, D., Vogelmeier, C., Barille, S., Nudo, E., Carter, V., Skinner, D., Vella, R., Georges, G.
International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 355—370
